Table 1.

Demographic features, IHCA features and outcomes of patients with COVID-19 IHCA.

			30-day survival		p-Value
		Total n = 260	No n = 228	Yes n = 32
Age, median (IQR)		69 (60–77)	69 (63–77)	60 (52–72)	<0.001
Gender	Male	186 (71.5%)	162 (71.1%)	24 (75.0%)	0.64
	Female	74 (28.5%)	66 (28.9%)	8 (25.0%)
Race/ethnicity:	Black	44 (16.9%)	33 (14.5%)	11 (34.4%)	0.02
	Hispanic	42 (16.2%)	38 (16.7%)	4 (12.5%)
	White	129 (49.6%)	119 (52.2%)	10 (31.2%)
	Other	38 (14.6%)	31 (13.6%)	7 (21.9%)
	Unknown	7 (2.7%)	7 (3.1%)	0 (0.0%)
Pre-existing comorbidities
	Hypertension	171 (65.8%)	148 (64.9%)	23 (71.9%)	0.44
	Hyperlipidaemia	100 (38.5%)	92 (40.4%)	8 (25.0%)	0.10
	Diabetes mellitus	114 (43.8%)	97 (42.5%)	17 (53.1%)	0.26
	Coronary artery disease	48 (18.5%)	42 (18.4%)	6 (18.8%)	0.96
	Chronic kidney disease	24 (9.2%)	18 (7.9%)	6 (18.8%)	0.05
	Metastatic/haematological malignancy	9 (3.5%)	9 (3.9%)	0 (0.0%)	0.25
	Cirrhosis	4 (1.5%)	2 (0.9%)	2 (6.2%)	0.02
Acute conditions	Sepsis	103 (39.6%)	94 (41.2%)	9 (28.1%)	0.16
	Hypotension	124 (47.5%)	112 (49.1%)	12 (37.5%)	0.22
	Hepatic insufficiency	11 (4.2%)	8 (3.5%)	3 (9.4%)	0.12
	Renal insufficiency	127 (48.8%)	112 (49.1%)	15 (46.9%)	0.81
Location of IHCA	Non-ICU	94 (36.2%)	87 (38.2%)	7 (21.9%)	0.07
	ICU	166 (63.9%)	141 (61.8%)	25 (78.1%)
Cardiac arrest witnessed	Yes	238 (91.5%)	209 (91.7%)	29 (90.6%)
	No	19 (7.3%)	17 (7.5%)	2 (6.2%)	0.53
	Unknown	3 (1.2%)	2 (0.9%)	1 (3.1%)
IHCA outcomes	ROSC	58 (22.3%)	–
	Survival to hospital discharge	31 (11.9%)	–
	30-day survival	32 (12.3%)	–
	CPC 1–2	16 (50.0%)	–
	CPC 3–4	10 31.3%)	–
	CPC 5	2 (6.3%)	–
	Unknown	4 (12.5%)	–

Abbreviations: CPC: Cerebral Performance Category; ICU: Intensive Care Unit.